Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Shanghai RAAS Blood Products Co Ltd

+ Add to Watchlist

002252:CH

63.450 CNY 0.750 1.20%

As of 23:10:06 ET on 05/05/2015.

Snapshot for Shanghai RAAS Blood Products Co Ltd (002252)

Open: 64.490 Day's Range: 62.900 - 64.490 Volume: 5,803,009
Previous Close: 62.700 52wk Range: 30.440 - 65.450 1-Yr Rtn: +95.84%

Stock Chart for 002252

No chart data available.
  • 002252:CH 63.450
  • 1D
  • 1M
  • 1Y
62.700
Interactive 002252 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002252

Current P/E Ratio (ttm) 94.0524
Estimated P/E(12/2015) 313.5000
Relative P/E vs. SZASHR 1.7512
Earnings Per Share (CNY) (ttm) 0.6667
Est. EPS (CNY) (12/2015) 0.2000
Est. PEG Ratio -
Market Cap (M CNY) 86,408.75
Shares Outstanding (M) 1,378.13
30 Day Average Volume 6,255,177
Price/Book (mrq) 9.5954
Price/Sale (ttm) 52.8280
Dividend Indicated Gross Yield 0.16%
Cash Dividend (CNY) 0.1000
Dividend Ex-Date 04/09/2015
5 Year Dividend Growth -5.22%
Next Earnings Announcement 08/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002252

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002252

Shanghai RAAS Blood Products Co. Ltd. specializes in the manufacture of plasma derived medical products for therapeutic use in the areas of immunology, hematology and intensive care medicines. Its subsidiaries and partner companies produce vaccines and Recombinant DNA pharmaceuticals.

Zheng YuewenChairmanHuang KaiVice Chairman
He Qiu "Meecham"PresidentYin JunExecutive Vice President
More Company Profile & Key Executives for 002252

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil